Service de parodontologie
Strasbourg, France
Location status: Recruiting
Location contact
Sophie JUNG
CONTACT
NCT Number: NCT04627857
Systemic sclerosis is a rare multisystem connective-tissue disorder characterized by three major pathological hallmarks: widespread fibrosis, vasculopathy and immunological abnormalities. This condition has multiple effects on the orofacial region that is involved in approximately 80% of the patients with a significant impact on the quality of life.
The aim of this randomized single-blind study is to evaluate the impact of the use of a specific oral hygiene instrumentation (sonic toothbrush and water flosser with a large handle) compared to "standard" toothbrushing with a manual toothbrush on the gingival health among patients with systemic sclerosis.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Strasbourg, France
Location status: Recruiting
Sophie JUNG
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients in group 1 (''reference procedure'') receive a manual toothbrush with a small compact head to facilitate access to the posterior teeth and soft bristles.
Time frame: day 0, week 2 and week 4
Contact information is provided by the study sponsor or research team.
University Hospital, Strasbourg, France
Other
Acronym: ScleroBross
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07292961
Behavior, Connective Tissue Diseases
Ankara, Altındağ, Turkey (Türkiye)
View Trial DetailsNCT06182293
Connective Tissue Diseases, Scleroderma Systemic
Strasbourg, France
View Trial DetailsNCT07085104
Autoimmune Diseases, Connective Tissue Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT07090226
Connective Tissue Diseases, Diffuse Cutaneous Scleroderma
Boston, Massachusetts, United States
View Trial Details